Skip to main content
. 2016 Nov 23;41(6):946–951. doi: 10.1177/0148607116680791

Table 1.

Characteristics of Patients Who Achieved Independence From PS With Teduglutide.

Age (y), Sex Colon-in- Continuity Remaining Small Intestine, cm Duration of PS Dependency at Start of TED, y PS Requirement at Start of TED, L/wk PS Infusion Requirement at Start of TED, Days per Week Weeks on TED at PS Weaning Cause for Resection
61, M Yes 80 6 3.5 3.5 12 Mesenteric infarction
54, M Yes 28 16 5.4 3 16 Mesenteric venous thrombosis
46, F No 250 1 3.5 3.5 28 Crohn’s disease
50, M No 250 1 13.0 6 32 Ulcerative colitis
66, M Yes 48 2 10.6 4.7 53 Ischemic bowel
39, M Yes 50 13 6.8 3 75 Injury
60, F No Unknown 2 6.3 3.5 79 Complications of surgery
66, F Yes 80 7 4.4 3 89 Radiation enteritis
46, M No Unknown 6 8.9 4 89 Crohn’s disease
34, M Yes 50 2 4.6 3 90 Mesenteric artery thrombosis
69, F Yes 120 5 3.5 3 101 Mesenteric arterial infarction
61, F Yes 76 1 4.1 4.5 101 Strangulated SI
63, M Yes 26 16 13.4 4.5 115 Mesenteric thrombosis
43, F Yes 40 2 4.5 5 126 Small bowel infarction
56, F Yes 50 2 9.4 6 127 Complications of surgery
41, F Yes 55 3 4.7 5.5 130 Injury

F, female; M, male; PS, parenteral support (parenteral nutrition and/or intravenous fluids); SI, small intestine; TED, teduglutide.